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carbapenemase‑producing Klebsiella pneumoniae emerged as a nosocomial pathogen causing 
morbidity and mortality in patients. for infection prevention it is important to track the spread of 
K. pneumoniae and its plasmids between patients. therefore, the major aim was to recapitulate the 
contents and diversity of the plasmids of genetically related K. pneumoniae strains harboring the 
beta‑lactamase gene blaKPC‑2 or blaKPC‑3 to determine their dissemination in the netherlands and the 
former Dutch Caribbean islands from 2014 to 2019. Next‑generation sequencing was combined with 
long‑read third‑generation sequencing to reconstruct 22 plasmids. wgMLST revealed five genetic 
clusters comprised of K. pneumoniae blaKPC‑2 isolates and four clusters consisted of blaKPC‑3 isolates. 
KpnCluster‑019 blaKPC‑2 isolates were found both in the netherlands and the caribbean islands, while 
blaKPC‑3 cluster isolates only in the netherlands. each K. pneumoniae blaKPC‑2 or blaKPC‑3 cluster was 
characterized by a distinct resistome and plasmidome. However, the large and medium plasmids 
contained a variety of antibiotic resistance genes, conjugation machinery, cation transport systems, 
transposons, toxin/antitoxins, insertion sequences and prophage‑related elements. The small 
plasmids carried genes implicated in virulence. Thus, implementing long‑read plasmid sequencing 
analysis for K. pneumoniae surveillance provided important insights in the transmission of a 
KpnCluster‑019 blaKPC‑2 strain between the netherlands and the caribbean.
Antimicrobial resistance is spreading rapidly among Enterobacterales, including Klebsiella pneumoniae, Escheri-
chia coli and Enterobacter spp.1. Within the cell, extra-chromosomal DNA such as plasmids encode genes that 
confer resistance to last resort antibiotics, including carbapenems and colistin, and can transfer between Entero-
bacterales2. Currently, carbapenemase-producing Enterobacterales (CPE) rank among the most problematic noso-
comial pathogens with limited outlook on novel effective  therapeutics3,4. With the current increase of multidrug-
resistant infections with CPE worldwide, total healthcare costs are anticipated to increase. K. pneumoniae is often 
referred to as the “canary in the coalmine”, as new antimicrobial resistance (AMR) genes have been associated 
with K. pneumoniae in the first clinical reports prior dispersal of the AMR genes among other Gram-negative 
 bacteria5. Most newly acquired AMR genes of K. pneumoniae are the result of horizontal gene transfer through 
conjugative  plasmids6–8. The K. pneumoniae carbapenemase KPC encoded by the blaKPC gene is an Ambler class A 
serine carbapenemase, which is often located on a transmissible plasmid-associated transposon Tn4401, or vari-
ants  hereof9–12. Tn4401 consists of flanking imperfect repeat sequences, a Tn3 transposase gene, a Tn3 resolvase 
gene and the ISKpn6 and ISKpn7 insertion  sequences10. The blaKPC-2 and blaKPC-3 carbapenemases are the most 
commonly identified variants that have spread globally and provide resistance to penicillins, carbapenems, 
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cephalosporins, cephamycins and  monobactams13,14. The KPC-2 and KPC-3 carbapenemases differ in only one 
amino acid as a histidine at position 272 is mutated to tyrosine (H272Y) in the KPC-3  variant15.
CPE isolates including K. pneumoniae are routinely send to the National Institute for Public Health and the 
Environment (RIVM) and are typed by Illumina next-generation sequencing (NGS) in the Dutch National CPE 
Surveillance program to identify AMR genes and to determine possible transmission of  strains16. NGS typi-
cally yields short sequence reads of 150 bases, thereby hampering the assembly of complete chromosomes and 
 plasmids17. This is often due to large mobile genetic elements, such as insertion sequence elements, transposons, 
and other repetitive sequences e.g. tandem repeat regions of > 1500 bp in size. However, combining Illumina 
NGS sequencing with long-read third generation sequencing (TGS), which produces 1000 to 500,000 bases or 
longer sequence reads, can overcome this problem and enables the reconstruction of chromosomes and complete 
 plasmids18,19. Currently, the transmission of K. pneumoniae between persons in the Netherlands and the Carib-
bean and the impact hereof is not thoroughly understood. Five percent of the K. pneumoniae isolates collected 
in the Dutch National CPE Surveillance Program are retrieved from the Caribbean. It is also not clear whether 
plasmids of K. pneumoniae circulate endemically in the Netherlands or are introduced from the Caribbean. 
blaKPC-type K. pneumoniae represent the third largest group (17.5%) of the K. pneumoniae isolates collected 
in the Dutch National CPE Surveillance Program after the blaOXA-48-type (48.5%) and blaNDM-1-type (24.3%) 
K. pneumoniae. While the prevalence of carbapenemase-producing K. pneumoniae and associated infections 
in the Netherlands is relatively low, the establishment of genomic surveillance of K. pneumoniae using TGS is 
of high  importance20,21. It provides for insights in the transmission of specific strains containing plasmids with 
AMR genes and/or virulence determinants. We therefore investigated the distribution of K. pneumoniae cluster 
isolates harboring blaKPC-2 or blaKPC-3 alleles obtained from the Dutch National CPE Surveillance Program and 
analyzed the contents of its plasmids using long-read third-generation sequencing.
Results
Distribution and genetic relationship of blaKPC‑2 and blaKPC‑3 carrying K. pneumoniae. A collec-
tion of 478 carbapenemase-producing K. pneumoniae isolates submitted to the Dutch National CPE Surveillance 
program from January  1st 2014 until June  30th 2019 to the National Institute for Public Health and the Environ-
ment (RIVM) were included in this study. The study collection comprised 84 K. pneumoniae blaKPC-positive 
isolates of which 51 contained the blaKPC-2 allele and 33 harbored the blaKPC-3 allele (Table  1). Sixty isolates 
originated from the Netherlands and 24 isolates originated from the Caribbean. Of the 24 Caribbean isolates, 22 
carried the blaKPC-2 allele and only two contained the blaKPC-3 allele. Whole genome multi-locus sequence typing 
(wgMLST), using an in-house wgMLST scheme based on 4,978 genes, of the 478 carbapenemase-producing K. 
pneumoniae isolates collected in the RIVM revealed that 23 K. pneumoniae blaKPC-2 isolates grouped together in 
five distinct genetic clusters. Fifteen K. pneumoniae blaKPC-3 isolates grouped in four distinct clusters which were 
obtained from the Netherlands and 46 isolates were unrelated. The K. pneumoniae cluster isolates (termed Kpn-
Clusters) had unique classical MLST sequence types, of which ST144 (KpnCluster-021) and ST560 (KpnClus-
ter-019) were not described previously (Table 1, Fig. 1). KpnCluster-003 and KpnCluster-005 were comprised of 
five K. pneumoniae blaKPC-2 isolates that were exclusively obtained from the Netherlands, while KpnCluster-021 
and KpnCluster-041 contained five isolates from the Caribbean. The majority (n = 10) of the KpnCluster-019 
isolates were obtained from the Caribbean. However, three isolates were from the collection of the Netherlands. 
One person from whom a KpnCluster-019 isolate was retrieved in August 2017 in the Netherlands, lived in the 
Caribbean until June 2017 and migrated to the Netherlands in July, demonstrating intercontinental transmission. 
Table 1.  Distribution of K. pneumoniae blaKPC-2 and blaKPC-3 isolates and resistance to meropenem. Based 
on the clinical breakpoints according to EUCAST, the isolates were classified as sensitive (S; < 2 mg/L), 
intermediate (I; ≥ 2 to 8 mg/L) and resistant (R; > 8 mg/L).
blaKPC allele KpnCluster
MLST The Netherlands Caribbean
TotalSequence type S I R S I R
blaKPC-2
KpnCluster-003 ST258 2 2
KpnCluster-005 ST258 3 3
KpnCluster-019 ST560 1 2 6 4 13
KpnCluster-021 ST144 1 2 3
KpnCluster-041 ST560 2 2
Non-KpnCluster variant 3 4 14 1 2 4 28
Subtotal 51
blaKPC-3
KpnCluster-008 ST512 4 4
KpnCluster-025 ST307 1 6 7
KpnCluster-038 ST11 2 2
KpnCluster-050 ST13 1 1 2
Non-KpnCluster variant 3 5 8 1 1 18
Subtotal 33
Total 8 12 40 10 7 7 84
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No epidemiological data could be retrieved from the other two Dutch KpnCluster-019 isolates. Furthermore, 
most genetic clusters were only distantly related to each other (Fig. 1). Based on wgMLST, the genetic distance 
between KpnCluster-019 and KpnCluster-041 was 30 alleles (0.6%) and for KpnCluster-003 and KpnCluster-005 
53 alleles (1.1%). KpnCluster-008 differed 132 alleles (2.65%) from KpnCluster-005. While the allelic difference 
between these clusters was low, the other genetic clusters differed 3573 to 3610 alleles (71.8–72.5%) from Kpn-
Cluster-005. This confirmed that most clusters were unrelated, and it is in line with the location of these genetic 
clusters in the minimum spanning tree. 
the resistome diversity among genetic clusters. Analysis of the NGS-derived resistomes of the clus-
ter and non-cluster isolates showed that K. pneumoniae harbored either the blaKPC-2 or the blaKPC-3 allele, none 
of the isolates carried both alleles (Fig. 2, Suppl. Figure 1). All of the K. pneumoniae isolates contained the fosA, 
oqxA and oqxB genes. An unweighted hierarchical clustering (UPGMA) based on the presence or absence of 
AMR genes revealed that most genetic cluster isolates group together per cluster, since the resistomes were more 
than 85% similar. In contrast to this, the resistomes of the non-cluster isolates were very diverse and less related 
since the resistomes of these isolates were less than 85% similar (Suppl. Figure 1). Likewise, the resistomes of 
one group of K. pneumoniae KpnCluster-003 blaKPC-2 and KpnCluster-008 blaKPC-3 cluster isolates with 53 to 
132 alleles difference were also unrelated. KpnCluster-019 isolates are unique when compared to the blaKPC-2 
clusters KpnCluster-003, KpnCluster-005, and KpnCluster-021, in that they carried aminoglycoside (aac(3)-IIa), 
extended spectrum beta-lactams (blaCTX-M-15, blaSHV-26), fluoroquinolone (qnrB1) and tetracyclin (tetA) 
antimicrobial resistance (AMR) genes. KpnCluster-019 and KpnCluster-041 isolates, obtained from the Carib-
bean, were closely related based on wgMLST, and group together based on the resistome too. The absence of 
AMR genes aph(3′’)-Ib, aph(6)-Id and sul2 in five of KpnCluster-019 isolates, including the TGS sequenced 
isolates, indicate the absence of an AMR gene containing plasmid. In addition, the presence of three KpnClus-
ter-019 isolates from the Netherlands with varying resistomes within the cluster suggests additional transmis-
sions. KpnCluster-025 blaKPC-3 isolates contained the aminoglycoside (aac(3)-IIa) and beta-lactam AMR genes 
(blaSHV-28), while the other Kpn blaKPC-3 clusters did not. Notably, mcr genes conferring resistance to colistin 
were not detected in the 84 isolates analyzed. The majority of the K. pneumoniae blaKPC-2 and blaKPC-3 isolates 































Figure 1.  Minimum spanning tree based on wgMLST of 478 sequenced K. pneumoniae isolates. Circles 
represent K. pneumoniae isolates, and the sizes of the circles indicate the numbers of isolates. Lines connecting 
the circles represent the genetic distance in numbers of alleles; the longer the connecting line, the larger the 
genetic distance. K. pneumoniae blaKPC-2 isolates were marked blue and K. pneumoniae blaKPC-3 were marked 
magenta. K. pneumoniae blaKPC-2 or blaKPC-3 cluster isolates that were sequenced with TGS were marked green. 
Genetic clusters were indicated with either a blue or a magenta halo around the circles, if two or more isolates 
differ ≤ 20 alleles. A categorical coefficient was used for the clustering. Cluster names are indicated. Inset: genetic 
distance between the KpnClusters in which the allelic difference is indicated by numbers.
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lates (30%) and 13 of the 15 blaKPC-3 cluster isolates (87%) were resistant to meropenem. The remainders of the 
cluster and non-cluster isolates were intermediate resistant or sensitive for meropenem (Table 1).
Antibiotic resistance genes among the genomic elements of the distinct genetic clus‑
ters. Long-read sequencing of seven isolates from six of the nine genetic K. pneumoniae blaKPC clusters 
with ≥ 3 isolates per cluster, revealed 22 plasmids with varying sizes (Fig.  3). Plasmids containing either the 
blaKPC-2 or blaKPC-3 allele were diverse in size. The large (≥ 150–250 kb) and medium (≥ 50–150 kb) sized plasmids 
contained one or two replicons from the incompatibility group IncFIB(K) and IncFII(K), IncHI2 and IncHI2a, or 
IncFIB(pQil) (Fig. 3). The small plasmids (< 50 kb) contained ColRNAI or IncX3/IncL/IncP6 type of replicons. 
The chromosomes of the analyzed isolates contained on average five acquired AMR genes, while the plasmids 
contained on average nine AMR genes. Sixteen of the 22 plasmids contained AMR genes from various classes 
and five plasmids from the isolate of KpnCluster-021 did not. The AMR genes conferring resistance to phenicol, 
trimethoprim and macrolide antibiotics were located only on medium or large sized plasmids. The small plas-
mids had one or two AMR genes conferring resistance to aminoglycosides or beta-lactams. Resistance genes for 
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Figure 2.  Resistome of K. pneumoniae blaKPC-2 and blaKPC-3 cluster isolates. K. pneumoniae blaKPC-2 and blaKPC-3 
cluster isolates were indicated on the y-axis and AMR genes on the x-axis. All isolates analysed contained the 
fosA, oqxA and oqxB AMR genes and were not included in this figure. The clustering was based on the presence 
(squares) and absence of AMR genes. Antibiotic classes are indicated above the AMR genes in different colors. 
Resistance genes in K. pneumoniae blaKPC-2 or blaKPC-3 cluster isolates that were sequenced with TGS were 
marked with green squares. Genetic relatedness was depicted in an UPGMA tree in which K. pneumoniae 
blaKPC-2 isolates were marked with blue branches, and K. pneumoniae blaKPC-3 were marked magenta. Dutch 
KpnCluster-019 isolates were marked with an *. A dotted line marks the 85% cut off.
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seven cluster isolates. KpnCluster-019 and KpnCluster-021 associated with the Caribbean contained plasmids 
encoding genes for phenicol and tetracyclin resistance. The KpnCluster-019 and KpnCluster-021 plasmids were 
not found in non-cluster isolates, whereas the plasmids of the other clusters were detected in a subset non-cluster 
isolates (Fig. 3). The plasmids of KpnCluster-003 and KpnCluster-005 were present in each of its cluster isolates, 
however, in isolates of the other clusters occasionally plasmids were lost, thereby impacting the composition of 
the resistome (Figs. 2 and 3).
The blaKPC-2 KpnCluster-019 isolates were obtained from both the Caribbean and the Netherlands, while 
blaKPC-2 KpnCluster-021 isolates originated only from the Caribbean (Table 1, Fig. 3). In the KpnCluster-019 
isolate RIVM_C014906, three copies of the blaKPC-2 gene were present, while other cluster isolates had only one 
blaKPC copy. One copy was located in the chromosome, one copy in the 200 kb plasmid pRIVM_C014906_1 and 
a third copy on the 16 kb plasmid pRIVM_C014906_3. All these three blaKPC-2 copies were located on a highly 
similar Tn4401a-derived ∆Tn4401a-like transposon of 5.6 kb in this strain. The chromosomes contained this 
∆Tn4401a-like transposon in the exact same region. KpnCluster-003, KpnCluster-005, KpnCluster-008 and 
KpnCluster-025 consist of isolates that were obtained in the Netherlands and in these isolates the blaKPC allele 
was located on a Tn4401a transposon of 10 kb.
comparison of the K. pneumoniae plasmid content among clusters. An UPGMA clustering based 
on the DNA sequence of the 22 plasmids from distinct genetic clusters revealed that the majority of the plas-
mids were unrelated (Fig. 4). The largest two plasmids pRIVM_C008981_1 from KpnCluster-003 and pRIVM_
C014947_1 from Kpncluster-021 carried the largest number of genes and this number decreased by the decreas-
ing size of the plasmids. Most these plasmid located genes had unknown function. The large and medium sized 
plasmids contained the klcA gene, encoding an antirestriction protein implicated in the facilitation of blaKPC 
allele  transfer22. None of the plasmids contained known virulence determinants such as rmpA, rmpA2, iroBC, or 
iucABC implicated in  hypervirulence23,24. Comparison of the large plasmids revealed that pRIVM_C008981_1 
and pRIVM_C015139_1 from KpnCluster-003 and KpnCluster-005 displayed 90% similarity (Fig. 4). Plasmid 
pRIVM_C014947_1 from KpnCluster-021 was not related to any other of the large plasmids. Despite the low 
similarity, these large plasmids from KpnClusters-003, -005, and -019, shared important clusters of genes among 
them. They all contained the silE and silP genes encoding a silver-binding protein and a silver exporting ATPase, 
cusSRCFB genes implicated in cation efflux, the copABCD-pcoE genes involved in copper resistance and the 
arsHACBAD arsenic resistance gene cluster. These large plasmids also contained fecIRABCDE implicated in 
Fe(3+)-dicitrate transport, the traIDSQCVAJM-ylpA plasmid conjugation gene cluster, and the higA-higA1 anti-
toxins, except pRIVM_C014947_1 from KpnCluster-021. In addition, the large plasmids also contained a pro-




































































































































































































cRIVM_C008981               █         █  █ █               KpnCluster-003
pRIVM_C008981_1 226,975    █    █    █      █ █   █   █     █    █  █      Tn4401a (NL) 2/2 7/61
cRIVM_C014906        █        █  █      █  █ █               KpnCluster-019
pRIVM_C014906_1 200,297        █          █                █  █      ∆Tn4401a-like (NL + Caribbean) 12/13 0/61
pRIVM_C014906_2 105,291 █  █    █    █          █  █      █  █           12/13
pRIVM_C014906_3 15,947        █          █               █         ∆Tn4401a-like 13/13 0/61
cRIVM_C018535        █        █  █      █  █ █               
pRIVM_C018535_1 200,152        █          █                █  █      ∆Tn4401a-like 12/13 0/61
pRIVM_C018535_2 15,947        █          █               █         ∆Tn4401a-like 13/13 0/61
cRIVM_C014947          █              █  █ █               KpnCluster-021
pRIVM_C014947_1 284,954   █   █     █         █       █  █  █    █ █    (Caribbean) 2/3
pRIVM_C014947_2 61,919                                       █   3/3
pRIVM_C014947_3 29,323        █                                █  ∆Tn4401a-like 3/3 0/61
pRIVM_C014947_4 5,596 3/3
pRIVM_C014947_5 4,938                                          3/3
pRIVM_C014947_6 3,223 3/3
pRIVM_C014947_7 2,750 █ 2/3
pRIVM_C014947_8 2,516                                          3/3
cRIVM_C015139               █         █  █ █               KpnCluster-005
pRIVM_C015139_1 209,317    █ █              █   █   █     █    █  █      (NL) 3/3
pRIVM_C015139_2 98,806     █   █    █      █                 █ █      Tn4401a 3/3 25/61
pRIVM_C015139_3 43,392              █                           █ 3/3
cRIVM_C015274    █           █         █  █ █   █            KpnCluster-008
pRIVM_C015274_1 115,525         █   █      █                 █ █      Tn4401a (NL) 4/4 6/61
pRIVM_C015274_2 43,380               █                          █ 4/4
pRIVM_C015274_3 13,636  █ █                              █         2/4
cRIVM_C015451             █    █       █  █ █               KpnCluster-025
pRIVM_C015451_1 114,360         █   █      █                 █ █      Tn4401a (NL) 7/7 9/61





































Figure 3.  Antimicrobial resistance genes on chromosomes and plasmids. The presence of AMR genes among 
the 22 plasmids of seven TGS sequenced isolates is indicated with black squares and for the chromosomes using 
green squares. Chromosomes (cRIVM_C0xxxx) and plasmids (pRIVM_C0xxxx) are depicted on the Y-axis, and 
AMR genes on the x-axis. Antibiotic classes are indicated above the AMR genes in different colors.
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KpnCluster 21 19 19 5 3 5 25 8 25 19 8 5 21 8 19 19 21 21 21 21 21 21
Gene product Gene
klcA █ █ █ █ █ █ █ █ █ █ █
Arsenical resistance operon arsA █ █ █ █ █
arsD █ █ █ █ █
arsB █ █ █ █ █
arsC █ █ █ █
Silver export system silP █ █ █ █
silE █ █ █ █
traI ████████
traQ █ █ █ █ █ █ █ █
traC █ █ █ █ █ █ █ █
traM █ █ █ █ █ █ █ █
traD █ █ █ █ █ █ █
ylpA █ █ █ █ █ █ █
traS █ █ █ █ █ █ █
traV █ █ █ █ █ █ █
traA █ █ █ █ █ █ █
traJ █ █ █ █ █ █ █
finO █ █ █ █ █ █ █
cusA █
cusS █ █ █ █
cusR █ █ █ █
cusC █ █ █ █
cusF █ █ █ █
cusB █ █ █ █
Copper resistance system copA █ █ █ █
pcoE █ █ █ █
copB █ █ █ █
pcoC █ █ █ █
copD █ █ █ █
copR █ █ █ █
sasA █ █ █ █




Fe(3+) dicitrate transport system fecI █ █ █ █
fecR █ █ █ █
fecA █ █ █ █
fecB █ █ █ █
fecC █ █ █ █
fecD █ █ █ █
fecE █ █ █ █
Virulence determinants flmA █ █ █ █ █
higA █ █ █ █ █ █
higA1 █ █ █ █ █ █
virB ████
pemI █ █ █ █














Figure 4.  K. pneumoniae plasmid gene content. An UPGMA clustering was performed based on the plasmid 
DNA sequence for the determination of the genetic relation among the 22 plasmids. Similarity is indicated on 
the y-axis using a scale from 0 (not similar) to 100% (identical). A similarity of ≥ 85 to 100% is regarded as the 
same plasmid. The plasmids are indicated on the x-axis. The presence (black squares) and absence is indicated 
of annotated genes among the 22 plasmids of seven TGS sequenced isolates. If a gene was present twice, blue 
squares were used and more than 2, red squares were used. Colors indicated different groups of genes with a 
specific function. In the UPGMA tree, large plasmids are indicated in red, medium plasmids in black and small 
plasmids in green color.
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Three medium-sized plasmids contained the virB virulence regulon transcriptional activator and the merAC 
mercuric reductase and transport protein. While pRIVM_C015274_1 from KpnCluster-008 and pRIVM_
C015451_1 from KpnCluster-025 contained a plasmid conjugation gene cluster, plasmids pRIVM_C014906_2, 
pRIVM_C015139_2, and pRIVM_C015451_2 contained truncated versions hereof. The more distantly related 
pRIVM_C014906_2 plasmid from KpnCluster-019 had in addition to the higA-higA1 antitoxins also a ccdA-
ccdB toxin-antitoxin system. The small plasmids (< 50 kb) contained genes implicated in virulence. Plasmids 
pRIVM_C015139_3 and pRIVM_C015274_2 displayed 99% similarity and carried the virD4-B9-B8-B4-ptlH 
Type IV secretion system. pRIVM_C014947_3 contained a merPT mercuric transport system, while pRIVM_
C014906_3 and pRIVM_C015274_3 carried a ceaC colicin-E3. The plasmid pRIVM_C014947_5 contained the 
bdlA gene encoding a biofilm dispersion protein.
transposable elements in K. pneumoniae plasmids from distinct clusters. The large and medium 
sized plasmids contained the most transposase sequences, and each plasmid had its unique transposon signature 
(Fig. 5). The IS1, IS110 and IS3 transposase families dominated in the K. pneumoniae plasmids among genetic 
clusters. The IS1 family transposase was found most frequently among the plasmids and in most copies within 
plasmids. In the large and medium sized plasmids, the blaKPC allele was located on a Tn4401a transposon, except 
in pRIVM_C014906_1 and pRIVM_C01835_1 from KpnCluster-019. In the small plasmids carrying a blaKPC, 
the carbapenemase allele was located on a ∆Tn4401a-like transposon. The large plasmids pRIVM_C008981_1, 
pRIVM_C015139_1 and pRIVM_C014906_1 from KpnClusters-003, -005, and -019 harbored 37, 32 and 31 
annotated tranposases, respectively. In contrast, the largest plasmid pRIVM_C014947_1 of 285 kb from Kpn-
Cluster-021 contained only 16 transposons. The remainder of the plasmids from KpnCluster-021 also contained 
very few transposase sequences, in contrast to the other plasmids from the different clusters. The highly related 
pRIVM_C015139_3 and pRIVM_C015274_2 plasmids (99% similarity) from KpnCluster-005 and KpnClus-
ter-008 had identical transposons. While IS66 and IS110 family transposase sequences also dominate in the large 
plasmids, the medium sized plasmids contained IS3 family type of transposases. The medium sized plasmids 
contained eleven to 23 transposases, and the small plasmids less than ten.
Similarity with previously reported plasmids. BLAST analysis of the K. pneumoniae plasmids identi-
fied in this study showed that 15 of the 22 plasmids were similar to previously reported plasmids in the NCBI 
sequence database (Table 2). These plasmids covered five distinct genetic clusters, except pRIVM_C008981_1 
from KpnCluster-003. To date, none of these plasmids of K. pneumoniae were reported to be implicated in 
healthcare-associated outbreaks. Plasmids pRIVM_C008981_1, pRIVM_C014906_1, pRIVM_C014906_3 con-
taining blaKPC-2 and pRIVM_C015274_1 harboring blaKPC-3 from distinct genetic clusters only had low sequence 
coverage 35–87% with plasmids present in the NCBI sequence database. The other blaKPC-2 and blaKPC-3 plasmids 
had high (93–99%) sequence coverage, indicating that these similar plasmids were detected previously by other 
researchers. Plasmids pRIVM_C014906_2, pRIVM_C015139_1, pRIVM_C015274_2 and pRIVM_C015274_3, 
not carrying a blaKPC allele, displayed 97–100% sequence coverage and 99–100% identity to plasmids isolated 
from K. pneumoniae from different countries (Table 2). Plasmids pRIVM_C014947_5 and pRIVM_C014947_6 
from KpnCluster-021 had 100% sequence coverage with 92.18 to 99.99% identity with plasmids isolated from 
Enterobacter hormaechei. Plasmids similar to the eight plasmids from KpnCluster-021 were detected previously 
in a variety of hosts, e.g. Salmonella enterica, K. pneumoniae, and E. hormaechei, suggesting these plasmids are 
broad-host range. The fact that 15 of the 22 plasmids analyzed in this study were found previously in distinct 
hosts, suggest international spread of these plasmids.
Prophage sequences in the K. pneumoniae cluster genomes. PHASTER analysis revealed that the 
majority of the large and medium-sized plasmids from different genetic clusters with IncFIB(K) or IncFIB(pQil) 
and IncFII(K) replicons contained one to four regions with prophage-related sequences e.g. genes encoding 
putative phage integrase, phage-like proteins, coat proteins, and/or tail shaft proteins (Table 3). The size of the 
prophage sequence regions varied per plasmid. The most commonly found prophage-related sequence in large 
and medium-sized plasmids of cluster isolates was an Escherichia phage RCS47 (Table 3). This sequence entails 
the 14.2 kb ygbMLKJI-blaSHV-recF-lacY region flanked by IS26 elements and representing 12% of the RCS47 
prophage genome. The small plasmids of < 50 kb lacked phage-related sequences. In contrast, the chromosomes 
of cluster isolates carried at least three to nine phage sequence regions covering 10–50% of the phage genome. 
These phage sequence regions covered a wide variety of distinct phages, including prophage sequences from 
Salmonella, Klebsiella, Cronobacter, Enterobacteria phages (Suppl. Table 1). The most commonly found prophage 
sequence in Klebsiella chromosomes was the Enterobacteria phage P4.
Discussion
We showed that a K. pneumoniae ST560 strain carrying blaKPC-2 from KpnCluster-019 was transmitted between 
the Netherlands and the Caribbean. This is based on the high genetic relatedness of the 13 isolates from KpnClus-
ter-019 as assessed by wgMLST and their highly similar resistome and plasmidome. We found that one person 
lived in the Caribbean and migrated to the Netherlands. After migration, a KpnCluster-019 isolate was obtained 
from this person in a Dutch hospital. Possibly other transmissions by other persons could have occurred, but 
these were not confirmed in this study. By combining short-read with long-read sequencing data, we identified 22 
plasmids of seven K. pneumoniae isolates from six distinct genetic clusters found in the Netherlands and the Car-
ibbean and analyzed these plasmids for its AMR gene profile, blaKPC transposons, replicons, transposon families, 
and gene content. The plasmid composition varied among the genetic clusters. Some of the cluster isolates had 
unique MLST sequence types (ST144 and ST560) which were not published previously and differ from globally 
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circulating extensively drug-resistant (XDR) K. pneumoniae ST258 and ST307  strains23,24. KpnCluster-019 is 
unique compared to the other cluster isolates analyzed in this study for the following reasons. First, KpnClus-
ter-019 harbors a unique and extensive set of AMR genes on the chromosome and in its plasmids. Secondly, 
KpnCluster-019 isolates were the only to contain three copies of the blaKPC-2 allele, two on two different plasmids 
and one in the chromosome. The localization of blaKPC-2 on the chromosome and additional blaKPC-2 copies have 
been reported previously and is further complicating the understanding of transmission of multidrug-resistant 
K. pneumoniae25,26. Thirdly, KpnCluster-019 and also KpnCluster-021 isolates from the Caribbean harbored the 
blaKPC-2 allele on a 5.6 kb ∆Tn4401a-like transposon, while the other isolates from the other genetic clusters from 
the Netherlands contained blaKPC on a 10 kb Tn4401a transposon. Most global descriptions of K. pneumoniae 
blaKPC the past decade have been associated with Tn4401a or isoforms  hereof9. The traditional association of 





















































































































































































Tn4401a █ █ █ █ █
Transposon Type
IS1 family transposase IS1A █ █ █ █ █ █ █ █ █ █ █ █
IS1D █ █ █
IS1R █ █ █ █
IS1X2 █ █ █ █
ISKpn14 █ █ █ █
ISPmi3 █ █ █ █ █ █ █
IS110 family transposase IS1663 █ █
IS4321R █ █ █ █ █
IS5075 █ █ █ █
ISEsa2 ███
IS1182 family transposase ISKpn6 █ █ █ █
IS1595 family transposase ISSsu9 █ █ █ █
IS200/IS605 family transposase IS609 ███
IS21 family transposase ISKpn7 █ █ █ █ █
IS3 family transposase IS103 █ █ █ █
IS1222 █ █
IS1400 █ █ █ █
ISEc52 █ █ █
ISEcl1 █ █ █ █
ISEhe3 █ █ █
ISKpn11 █ █ █ █
ISKpn18 █ █ █
ISKpn38 █ █ █ █
ISKpn8 █ █ █ █
ISEc14 █
ISSen4
IS4 family transposase IS421 █ █ █
ISVsa5 █
IS481 family transposase ISKpn28 █ █ █
IS5 family transposase IS903 ████
ISKpn26 █ █
ISThi1 ███










ISAs1 family transposase ISKpn31 █ █




ISNCY family transposase ISBcen27 █ █ █
ISKpn21 █ █ █
ISLad2 █











Large ≥150-250 kb Medium ≥50-150 kb Small <50 kb
Figure 5.  K. pneumoniae plasmid-localized transposases. The presence (black squares) and absence is indicated 
of annotated transposases among the 22 plasmids of six TGS sequenced isolates. The plasmids are indicated on 
the x-axis. If a transposon was present twice, blue squares were used and more than 2, red squares were used. 
The light grey area indicates specific transposons found in only one plasmid. In the UPGMA tree, large plasmids 
are indicated in red, medium plasmids in black and small plasmids in green color.
9
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:16778  | https://doi.org/10.1038/s41598-020-73440-2
www.nature.com/scientificreports/
to a smaller variant. This is the first report of identification of a 5.6 kb ∆Tn4401a-like blaKPC-2 transposon of K. 
pneumoniae in the Netherlands. Preliminary surveillance data analysis revealed that the ∆Tn4401a-like element 
carrying blaKPC-2 and smaller variants disseminated among E. cloacae, Serratia marcesens, K. oxytoca and E. coli 
in the Netherlands (unpublished data). Future work will seek to understand the dissemination of the ∆Tn4401a-
like blaKPC-2 element among CPE in the Netherlands. Lastly, the plasmids of KpnCluster-019 isolates contained 
also unique plasmid content, including a distinct transposon signature, two toxin-antitoxin systems and a ceaC 
colicin which possibly contribute to the success in survival, niche adaptation or transmission of this strain.
The K. pneumoniae blaKPC-3 isolates had higher MICs for meropenem than the K. pneumoniae blaKPC-2 isolates, 
which is in line with a previous  study21. The KPC-2 enzyme differs in a single amino acid substitution (Histidine 
272 to Tyrosine) from KPC-3. Additional changes in KPC-3 can lead to increased resistance for ceftazidime and 
 cephamycin27. The increase in meropenem resistance observed in our study is possibly correlated with improved 
ability of KPC-3 enzymes to hydrolyze the meropenem  antibiotic15. Alternatively, additional beta-lactamase genes 
such as blaOXA-1, blaOXA-9 or blaTEM-1A may contribute to increased resistance for  meropenem28.
Despite the limited number of long-read sequenced isolates, we have highlighted important new insights in 
the genomic surveillance of a notorious multi-antibiotic resistant nosocomial pathogen. In some clusters, the 
plasmidome varied as this was likely due to loss of a plasmid. Also, the resistome data suggest the presence of 
other plasmids in cluster isolates that were not present in the isolates that were sequenced using TGS. To over-
come this limitation, all isolates used in this study should have been sequenced using long-read third generation 
Table 2.  BLAST similarity analysis of K. pneumoniae plasmids.









number Country Year Reference
pRIVM_
C008981_1 KpnCluster-003 blaKPC-2 K. pneumoniae pGMI16-005_01 35 99.96 CP028181.1 Denmark 2013
pRIVM_





moniae plasmid pG747 97 99.84 CP034137.1 Nigeria 2013
pRIVM_
C014906_3 blaKPC-2 K. pneumoniae unnamed5 58 99.97 CP033630.1 Italy 2013 Roe et al. (2019)
43
pRIVM_
C018535_1 blaKPC-2 K. pneumoniae pKPN1482-1 63 99.91 CP020842.1 USA 2014 Long et al. (2017)
42
pRIVM_
C018535_2 blaKPC-2 K. pneumoniae unnamed5 58 99.97 CP033630.1 Italy 2013 Roe et al. (2019)
43
pRIVM_
C014947_1 KpnCluster-021 S. enterica pSJO-60984 93 99.99 CP025277.1 USA 2007
pRIVM_
C014947_2 K. pneumoniae unnamed3 90 99.98 CP032170.1 USA 2015
pRIVM_
C014947_3 blaKPC-2 K. pneumoniae pA1705-KPC 93 99.97 MH909348.1 China 2013
pRIVM_
C014947_4 K. pneumoniae pKP18-2079_5kb 100 100 MT090963.1 China 2018
pRIVM_
C014947_5 E. hormaechei pC4_003 100 99.97 CP042543.1 Australia 2007
pRIVM_
C014947_6 K. pneumoniae pD17KP0032-3 100 100 CP052331.1 S. Korea 2017
pRIVM_
C014947_7 E. hormaechei unnamed3 97 100 CP035388.1 UK 2016
pRIVM_
C014947_8 E. hormaechei pC45-004 100 99.69 CP042555.1 Australia 2013
pRIVM_
C015139_1 KpnCluster-005 K. pneumoniae plasmid 2 100 99.99 LR130549.1 Australia 2018
pRIVM_
C015139_2 blaKPC-2 K. pneumoniae pUJ-83KPC 99 98.55 MG700549.1 Germany 2017
pRIVM_
C015139_3 K. pneumoniae pBK13043-2 100 99.89 CP020839.1 USA 2004 Long et al. (2017)
42
pRIVM_
C015274_1 KpnCluster-008 blaKPC-3 K. pneumoniae plasmid p2 87 99.91 CP019774.1 Switzerland 2015 Ruppe et al. (2017)
44
pRIVM_
C015274_2 K. pneumoniae pBK13043-2 100 99.95 CP020839.1 USA 2004 Long et al. (2017)
42
pRIVM_




C015451_1 KpnCluster-025 blaKPC-3 K. pneumoniae pKPC 99 99.99 CP043971.1 France 2019
pRIVM_
C015451_2 K. pneumoniae p911021-tetA 66 99.55 MG288679.1 China 2019
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sequencing. Nevertheless, we identified plasmids in K. pneumoniae blaKPC-2 and blaKPC-3 cluster isolates which 
vary in size from large, medium and small. The large and medium sized plasmids were enriched for a variety of 
transposons, conjugation transfer systems, cation efflux systems including Fe(3+)-dicitrate transport, and genes 
encoding for silver, copper and arsenic resistance. The small plasmids contained putative virulence determinants. 
The presence of these systems may contribute to the success of transmission of specific K. pneumoniae strains in 
the hospital setting or the  community13,29,30. Escherichia RCS47 prophage sequences were found on medium and 
large plasmids in the cluster isolates analyzed. In contrast, the chromosomes contained a variety of prophage-
related sequences. RCS47 is a P1-like bacteriophage carrying the ESBL-encoding blaSHV-2 gene was isolated from 
a clinical E. coli  strain31. The prevalence of P1-like prophages in animal and human E. coli strain collections was 
12.6%31. The presence of P1-like phage sequences in plasmids of a snapshot of the K. pneumoniae population in 
the Netherlands and the Caribbean suggest that the role of P1-like phages in disseminating antibiotic resistance 
may be  underestimated32.
In conclusion, long-read sequencing contributed to the understanding of the successful transmission of the 
KpnCluster-019 K. pneumoniae blaKPC-2 strain. Plasmid content such as conjugation machinery, transposons, 
virulence determinants and phages may contribute to diversification, and dissemination of plasmids containing 
AMR genes, and therefore represent important plasmid features that warrants future investigation. More long-
read plasmid sequencing efforts of CPE and K. pneumoniae in particular are required to identify the complete 
plasmid reservoir involved in the spread of antibiotic resistance determinants in the Netherlands and the Carib-
bean islands.
Methods
Bacterial isolates. For the Dutch National carbapenemase-producing Enterobacterales (CPE) Surveillance 
program, medical microbiology laboratories from the Netherlands and the Caribbean routinely send CPE iso-
lates with a meropenem minimum inhibitory concentration (MIC) of ≥ 0.25 µg/ml and/or an imipenem MIC 
of ≥ 1 µg/ml or phenotypic (CIM-test) or genotypical evidence of carbapenemase production to the National 
Institute of Public Health and the Environment (RIVM)16. For this study, 84 carbapenemase-producing K. pneu-
moniae isolates carrying either the blaKPC-2 allele or the blaKPC-3 allele were included and collected in the period 
from January 1st 2014 until June 30th 2019. Only the first K. pneumoniae isolate per person in this study period 
was selected. The 84 isolates were obtained from 84 persons and from various isolation sites, i.e. rectum/peri-
neum (n = 43), throat (n = 11), pus (n = 2), sputum (n = 4), urine (n = 10), wound (n = 5) and nine were from mis-
cellaneous isolation sites. All bacterial strains were grown aerobically at 37 °C on Columbia sheep blood agar 
plates.
Antimicrobial susceptibility testing. Resistance to carbapenem was confirmed by assessing the MICs 
for meropenem for all the 84 isolates using an Etest (bioMérieux Inc., Marcy l’Etoile, France). Based on the 
clinical breakpoints according to EUCAST, the K. pneumoniae isolates were classified as sensitive (≤ 2 mg/L), 
Table 3.  Predicted prophage sequences among K. pneumoniae plasmids.
Plasmid(s) blaKPC allele Phage region(s) length (kb) Most common phage Accession number
pRIVM_C008981_1 blaKPC-2 11.3 Escherichia phage RCS47 NC_042128
pRIVM_C014906_1 blaKPC-2 7, 3.2, 23.3, 5.1, 5.7 Stx2-converting phage 1717 NC_011357
pRIVM_C014906_2 43.6 Escherichia phage RCS47 NC_042128
pRIVM_C014906_3 blaKPC-2
pRIVM_C018535_1 blaKPC-2 7, 3.2, 23.3, 5.1, 5.7 Stx2-converting phage 1717 NC_011357
pRIVM_C018535_2 blaKPC-2








pRIVM_C015139_1 23.5, 11.3 Stx2-converting phage 1717, Escheri-chia phage RCS47 NC_011357, NC_042128
pRIVM_C015139_2 blaKPC-2 30.8 Escherichia phage RCS47 NC_042128
pRIVM_C015139_3 24.8 Escherichia phage RCS47 NC_042128
pRIVM_C015274_1 blaKPC-3 38.7 Escherichia phage RCS47 NC_042128
pRIVM_C015274_2 24.8 Escherichia phage RCS47 NC_042128
pRIVM_C015274_3
pRIVM_C015451_1 blaKPC-3 39.5 Escherichia phage RCS47 NC_042128
pRIVM_C015451_2 20.6 Staphylococcus phage SPbeta-like NC_029119
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intermediate (> 2  mg/L and ≤ 8  mg/L) and resistant (> 8  mg/L) to meropenem. In addition, all isolates were 
analyzed for the production of carbapenemase using the carbapenem inactivation method (CIM) as described 
 previously33.
Next‑generation sequencing, MLST and wgMLST. All 84 K. pneumoniae isolates were subjected to 
next-generation sequencing (NGS) using the Illumina HiSeq 2500 (BaseClear, Leiden, the Netherlands). The 
NGS data of the K. pneumoniae isolates were used for classical MLST and wgMLST analyses using the in-house 
wgMLST scheme in SeqSphere software version 6.0.2 (Ridom GmbH, Münster, Germany). The in-house K. 
pneumoniae wgMLST scheme was comprised of 4978 genes (3471 core-genome and 1507 accessory-genome tar-
gets) using K. pneumoniae MGH 78,578 (NC_009648.1) as a reference  genome21. For classical MLST, the existing 
scheme was used and cluster nomenclature were depicted in Table 1 34. The resulting data was imported into 
Bionumerics version 7.6.3 for subsequent comparative analyses (Applied Maths, Sint-Martens-Latem, Belgium). 
The antibiotic resistance gene profile and plasmid replicon compositions in all of the isolates were determined by 
interrogating the online ResFinder (version 3.1.0) and PlasmidFinder (version 2.0.2) databases available at the 
Center for Genomic Epidemiology website (https ://cge.cbs.dtu.dk/servi ces/)35,36. For ResFinder, a 90% identity 
threshold and a minimum length of 60% were used as criteria, whereas for PlasmidFinder, an identity of 95% 
was utilized.
Long‑read third‑generation sequencing. One K. pneumoniae isolate per genetic KpnCluster was 
sequenced using long-read third-generation Nanopore  sequencing18,37. High molecular weight DNA was iso-
lated using an in-house developed protocol. Bacteria were grown overnight in 1.5 ml Brain heart infusion broth 
and culture was spun down at 13,000 × g for 2 min. The pellet was washed and resuspended in 500 µl of 150 mM 
NaCl. The suspension was spun down at 5000 × g for 5 min and the pellet was resuspended in 100 µl of Quick-
Extract DNA Extraction Solution (Lucigen) and 0.1 µl Ready-Lyse Lysozyme solution (Epicentre) and incubated 
for 1 h at 37 °C. Subsequently, 85 µl 10 mM Tris 1 mM EDTA pH = 8 (1 × TE), 10 µl proteinase K (> 600 mAU/
mL, Qiagen) and 5 µl 20% sodium dodecyl sulfate solution were added, and the mixture was incubated at 56 °C 
for 30 min. DNA was precipitated overnight at -20 °C by adding 0.1 × volume 3 M sodium acetate pH = 5.2 and 
2.5 × volume ice cold 100% ethanol. Precipitated DNA was spun down at 13,000 × g for 15 min and pellets were 
washed with 1 ml 70% ethanol followed by another centrifugation at 13,000 × g for 5 min. After drying, the pellet 
was dissolved in 200 µl 1 × TE and diluted to 1 µg with Nuclease-free water.
The Oxford Nanopore protocol SQK-LSK108 (https ://commu nity.nanop orete ch.com) and the expansion kit 
for native barcoding EXP-NBD104 was used. Briefly, a shearing step was performed using g-TUBE’s (Covaris) 
to obtain an average DNA fragment size of 8 kb. The DNA was repaired using FFPE and end-repair kits (New 
England BioLabs) followed by ligation of barcodes with bead clean up using AMPure XP (Beckman Coulter) 
after each step. Barcoded isolates were pooled and sequencing adapters were added by ligation. The final library 
was loaded onto a MinION flow cell (MIN-106 R9.4.1). The 48-h sequence run was started without live base 
calling enabled on a MinION device connected to a desktop computer. After the sequence run, base calling and 
de-multiplexing was performed using Albacore 2.3.1 and a single FASTA file per isolate was extracted from the 
FAST5 files using Poretools 0.5.138. Illumina and Nanopore data were used in a hybrid assembly performed by 
Unicycler v0.4.439. The resulting contig files were annotated using Prokka and were subsequently loaded into 
BioNumerics for further  analyses40.
Minimum spanning tree and UpGMA analyses. The BioNumerics software was used to generate a 
minimum spanning tree (MST) or an UPGMA hierarchical clustering as described  previously16. The MST was 
based on an in-house K. pneumoniae wgMLST scheme. The categorical coefficient was used to calculate the 
MST. wgMLST clusters were defined as a minimum of two isolates of which the genetic distance between the two 
isolates was ≤ 20 genes (20/4978  ≤ 0.4% different). An UPGMA clustering of K. pneumoniae blaKPC-2 and blaKPC-3 
isolates was performed based on the presence and/or absence of antibiotic resistance genes per isolate.
plasmid reconstruction by read mapping. The CLC Genomics Workbench version 12.0 software 
(www.qiage nbioi nform atics .com) was used to reconstruct plasmids. For this, complete plasmids obtained by 
TGS were used as a scaffold to map the trimmed NGS reads of isolates that were from the same genetic wgMLST 
cluster. A plasmid was scored “present” in an isolate if reads mapped to a reference plasmid of interest and ≥ 85% 
of the consensus sequence size in kilo bases was reconstructed. Linear DNA fragments < 5 kb were omitted in 
this study. Nucleotide BLAST analyses on plasmid sequences were performed using the https ://blast .ncbi.nlm.
nih.gov website and date from October 2019.
plasmid content analysis. Bionumerics was used to extract and analyze annotated genes and tranposases 
in the 22 different plasmids. The data was plotted in Excel. Phaster, the PHAge Search Tool Enhanced Release 
website (https ://phast er.ca/) was used to determine the presence of phage sequences in the plasmids and searches 
date from October  201941.
ethics statement. The bacterial isolates used in this study belong to the medical microbiological laborato-
ries participating in the Dutch National CPE Surveillance program and was obtained as part of routine clinical 
care in the past. Since no identifiable personal data were collected and data were analyzed anonymously, written 
or verbal patient consent was not required for this study and was therefore not obtained. According to the Dutch 
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Medical Research Involving Human Subjects Act (WMO) this study was considered exempt from review by an 
Institutional Review Board.
Data availability
The Illumina (NGS) and plasmid sequence data sets generated and analyzed in this study are freely available in 
the Sequence Read Archive (SRA) under BioProject ID PRJNA634885 and in Genbank under accession numbers 
as depicted in Supplementary Table 2.
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